Physician profile
Randi J Ryan
NPI 1013322759
$6,081.56
in general payments reported to CMS, 2019-2025
9 companies · $4,661 in 2025
The $4,661 reported for 2025 was more than what 84% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.55 · 2020: $98.84 · 2023: $85.29 · 2024: $1,198 · 2025: $4,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,821 · Education: $2,518 · Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,821.05 |
| Education | $2,518.09 |
| Food and Beverage | $605.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,660.72 | 2025 | |
| Histosonics, INC. | $1,126.84 | 2024 | |
| Tela Bio, INC. | $98.84 | 2020 | |
| Organox LTD | $85.29 | 2023 | Metra |
| Ethicon US, LLC | $27.21 | 2024 | Certus 140 |
| Haemonetics Corporation | $26.02 | 2024 | Teg6s Hemostasis System |
| Kci USA, INC. | $22.99 | 2019 | |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Bridion |
| Teleflex LLC | $15.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randi Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.